Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Molan

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of General Virology|May 31, 2019
HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1Terumasa Ikeda, Amy M Molan, Matthew C Jarvis, et al.
Virology|August 26, 2017
APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localizationAmy M Molan, Heather M Hanson, Cynthia M Chweya, et al.
Internal Medicine Journal|June 22, 2010
Multidisciplinary approach to carotid stentingC S Mak, B R Chambers, D J Clark, et al.
Cancer Research|October 1, 2015
The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancersBrandon Leonard, Jennifer L McCann, Gabriel J Starrett, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3BWilliam L Brown, Emily K Law, Prokopios P Argyris, et al.
Science Advances|October 13, 2016
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancerEmily K Law, Anieta M Sieuwerts, Kelly LaPara, et al.
Cancer Immunology Research|April 4, 2019
Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line TreatmentLaura Evgin, Amanda L Huff, Timothy Kottke, et al.
Cancer Research|January 25, 2019
<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal TumorsPauline J Beckmann, Jon D Larson, Alex T Larsson, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of General Virology|May 31, 2019
HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1Terumasa Ikeda, Amy M Molan, Matthew C Jarvis, et al.
Virology|August 26, 2017
APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localizationAmy M Molan, Heather M Hanson, Cynthia M Chweya, et al.
Internal Medicine Journal|June 22, 2010
Multidisciplinary approach to carotid stentingC S Mak, B R Chambers, D J Clark, et al.
Cancer Research|October 1, 2015
The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancersBrandon Leonard, Jennifer L McCann, Gabriel J Starrett, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3BWilliam L Brown, Emily K Law, Prokopios P Argyris, et al.
Science Advances|October 13, 2016
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancerEmily K Law, Anieta M Sieuwerts, Kelly LaPara, et al.
Cancer Immunology Research|April 4, 2019
Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line TreatmentLaura Evgin, Amanda L Huff, Timothy Kottke, et al.
Cancer Research|January 25, 2019
<i>Sleeping Beauty</i> Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal TumorsPauline J Beckmann, Jon D Larson, Alex T Larsson, et al.
Pageof 3